Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04910126
Brief Title: Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

First Submitted : May 24, 2021
First Submitted that Met QC Criteria : June 1, 2021
First Posted : June 2, 2021

Last Update Submitted that Met QC Criteria : June 1, 2021
Last Update Posted : June 2, 2021